Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Brazilian: cost-cuts promise more cash for medical technology

This article was originally published in Clinica

Executive Summary

The significant savings that should result from a Brazilian initiative to rationalise the purchasing of high-cost medicines will be invested in increasing access to certain medical procedures and basic healthcare products. So said the health ministry of an e-tendering and price-referencing register for so-called "exceptional medicines", launched at the end of November. The programme is expected to halve the cost of some of these medicines, which make up a market worth R$1.2bn (US$540m).

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT058081

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel